[go: up one dir, main page]

DE69618987D1 - Injizierbare quinolonformulierungen - Google Patents

Injizierbare quinolonformulierungen

Info

Publication number
DE69618987D1
DE69618987D1 DE69618987T DE69618987T DE69618987D1 DE 69618987 D1 DE69618987 D1 DE 69618987D1 DE 69618987 T DE69618987 T DE 69618987T DE 69618987 T DE69618987 T DE 69618987T DE 69618987 D1 DE69618987 D1 DE 69618987D1
Authority
DE
Germany
Prior art keywords
quinolon
injectable
formulas
quinolon formulas
injectable quinolon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69618987T
Other languages
English (en)
Other versions
DE69618987T2 (de
Inventor
Alan Boettner
Connor Canning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21735307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69618987(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of DE69618987D1 publication Critical patent/DE69618987D1/de
Application granted granted Critical
Publication of DE69618987T2 publication Critical patent/DE69618987T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69618987T 1995-12-21 1996-11-13 Injizierbare quinolonformulierungen Expired - Lifetime DE69618987T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US905295P 1995-12-21 1995-12-21
PCT/IB1996/001217 WO1997023217A1 (en) 1995-12-21 1996-11-13 Injectable quinolone formulations

Publications (2)

Publication Number Publication Date
DE69618987D1 true DE69618987D1 (de) 2002-03-14
DE69618987T2 DE69618987T2 (de) 2002-11-21

Family

ID=21735307

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618987T Expired - Lifetime DE69618987T2 (de) 1995-12-21 1996-11-13 Injizierbare quinolonformulierungen

Country Status (42)

Country Link
US (1) US5811130A (de)
EP (1) EP0868183B1 (de)
JP (1) JP3416145B2 (de)
KR (1) KR100402570B1 (de)
CN (1) CN1104899C (de)
AP (1) AP706A (de)
AR (1) AR005147A1 (de)
AT (1) ATE212551T1 (de)
AU (1) AU709474B2 (de)
BG (1) BG63933B1 (de)
BR (1) BR9612230A (de)
CA (1) CA2239352C (de)
CO (1) CO4480098A1 (de)
CZ (1) CZ293747B6 (de)
DE (1) DE69618987T2 (de)
DK (1) DK0868183T3 (de)
DZ (1) DZ2146A1 (de)
EG (1) EG24071A (de)
ES (1) ES2167609T3 (de)
GT (1) GT199600098A (de)
HR (1) HRP960607B1 (de)
HU (1) HU227918B1 (de)
IL (1) IL124454A (de)
IS (1) IS2010B (de)
MA (1) MA24035A1 (de)
MX (1) MX9805026A (de)
MY (1) MY117109A (de)
NO (1) NO315734B1 (de)
NZ (2) NZ320545A (de)
OA (1) OA10697A (de)
PE (1) PE25798A1 (de)
PL (1) PL186795B1 (de)
PT (1) PT868183E (de)
RS (1) RS49523B (de)
RU (1) RU2141827C1 (de)
SI (1) SI0868183T1 (de)
SK (1) SK284412B6 (de)
TN (1) TNSN96163A1 (de)
TW (1) TW449475B (de)
UA (1) UA56151C2 (de)
WO (1) WO1997023217A1 (de)
ZA (1) ZA9610780B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21415A (id) * 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
US20030153585A1 (en) * 2000-01-13 2003-08-14 Sven-Alexander Schreder Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
CA2680475A1 (en) * 2000-12-28 2002-07-11 Shigeyuki Takada Sustained-release preparation
JP2005535644A (ja) * 2002-06-26 2005-11-24 ファルマシア コーポレイション 安定な非経口パレコキシブ液体製剤
EP1764102A4 (de) * 2004-07-02 2010-08-25 Daiichi Seiyaku Co Chinolon-haltige medizinische zusammensetzung
PL2594272T3 (pl) * 2005-05-18 2018-11-30 Horizon Orphan Llc Fluorochinolony w aerozolu i ich zastosowania
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
FR2896416B1 (fr) 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
LT1991201T (lt) * 2006-02-10 2018-07-25 Pari Pharma Gmbh Puškiami antibiotikai inhaliaciniam gydymui
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
WO2010042549A1 (en) 2008-10-07 2010-04-15 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
WO2010042553A1 (en) 2008-10-07 2010-04-15 Mpex Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
JP6180012B2 (ja) 2009-09-04 2017-08-16 ラプター ファーマスーティカルズ，インコーポレイテッド 嚢胞性線維症を治療するためのエアロゾル化レボフロキサシンの使用
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
US10406149B2 (en) 2015-06-02 2019-09-10 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid formulation
WO2016195014A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
JP6675396B2 (ja) 2015-06-02 2020-04-01 杏林製薬株式会社 水性液剤
CN110248643B (zh) * 2017-02-13 2023-11-24 拜耳动物保健有限责任公司 含普拉沙星的液体组合物
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US523505A (en) * 1894-07-24 Island
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
JPS63188626A (ja) * 1987-01-30 1988-08-04 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸の可溶化方法
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
EP0507851B1 (de) * 1989-12-29 1997-04-02 Abbott Laboratories Chinoloncarbonsäure-metallionsäurekomplexe
US5084276A (en) * 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
EP0443381B2 (de) * 1990-02-14 1997-10-22 Takeda Chemical Industries, Ltd. Brausemischung, deren Herstellung sowie Verwendung
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
JPH0782141A (ja) * 1993-09-17 1995-03-28 Tanabe Seiyaku Co Ltd 動物用注射剤

Also Published As

Publication number Publication date
BG63933B1 (bg) 2003-07-31
MX9805026A (es) 1998-09-30
AU7328996A (en) 1997-07-17
HUP9903726A2 (hu) 2000-04-28
CN1205636A (zh) 1999-01-20
CA2239352C (en) 2002-06-04
NZ501160A (en) 2001-10-26
EP0868183A1 (de) 1998-10-07
IS4755A (is) 1998-05-25
KR100402570B1 (ko) 2003-12-18
CN1104899C (zh) 2003-04-09
PL186795B1 (pl) 2004-02-27
YU69096A (sh) 1999-06-15
NO315734B1 (no) 2003-10-20
IL124454A (en) 2003-10-31
RS49523B (sr) 2006-10-27
TNSN96163A1 (fr) 2005-03-15
SK284412B6 (sk) 2005-03-04
BG102542A (en) 1999-06-30
IL124454A0 (en) 1998-12-06
AP706A (en) 1998-12-04
AU709474B2 (en) 1999-08-26
NO982842L (no) 1998-06-19
SI0868183T1 (en) 2002-04-30
MY117109A (en) 2004-05-31
ES2167609T3 (es) 2002-05-16
IS2010B (is) 2005-05-13
JPH11501331A (ja) 1999-02-02
CZ293747B6 (cs) 2004-07-14
PT868183E (pt) 2002-06-28
ATE212551T1 (de) 2002-02-15
CO4480098A1 (es) 1997-07-09
OA10697A (en) 2001-05-04
UA56151C2 (uk) 2003-05-15
PL328001A1 (en) 1999-01-04
RU2141827C1 (ru) 1999-11-27
PE25798A1 (es) 1998-05-21
DE69618987T2 (de) 2002-11-21
SK80798A3 (en) 1999-09-10
KR19990076617A (ko) 1999-10-15
MA24035A1 (fr) 1997-07-01
ZA9610780B (en) 1998-06-22
TW449475B (en) 2001-08-11
US5811130A (en) 1998-09-22
EG24071A (en) 2008-05-11
NZ320545A (en) 2000-03-27
HUP9903726A3 (en) 2001-01-29
DZ2146A1 (fr) 2002-10-23
JP3416145B2 (ja) 2003-06-16
HU227918B1 (en) 2012-06-28
HRP960607B1 (en) 2002-06-30
DK0868183T3 (da) 2002-03-25
WO1997023217A1 (en) 1997-07-03
CZ193098A3 (cs) 1999-05-12
AR005147A1 (es) 1999-04-14
BR9612230A (pt) 1999-07-13
CA2239352A1 (en) 1997-07-03
NO982842D0 (no) 1998-06-19
HRP960607A2 (en) 1998-06-30
GT199600098A (es) 1998-06-12
EP0868183B1 (de) 2002-01-30
AP9600898A0 (en) 1997-01-31

Similar Documents

Publication Publication Date Title
DE69618987D1 (de) Injizierbare quinolonformulierungen
DE59609887D1 (de) Substituierte cyanophenyluracile
DE59602881D1 (de) Sollwertgeber
FI951018A0 (fi) Hoeghastighetsdataoeverfoering i mobiltelesystem
DE59610332D1 (de) Substituierte aminouracile
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
BR9608890A (pt) N-metilenotiouréias substituídas
DE59601292D1 (de) Schutzplankenanordnung
ATE198470T1 (de) Alkenyl-benzoylguanidine
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de) Substituierte benzylidencyanessigester
ATE240972T1 (de) Cyclopeptolide
DE59607958D1 (de) Substituierte phenyluracile
KR960029102U (ko) 가족 납골묘
FI2204U1 (fi) Lyftmekanism foer en saekerhetskant i en saeng
FI1872U1 (fi) I dryckesbackar anvaendbart reklammaterial
FI1900U1 (fi) Spejningsbraeda foer katter i hoeghus
FI1803U1 (fi) Anordning i saollskopa
FI2050U1 (fi) Rullstol foer fastmontering i fordonsgolv
FI2190U1 (fi) Stoedkonstruktion foer sprutroer i en pappersmaskin/kartongmaskin
BR7500363U (pt) Formulário
FI953322A0 (fi) Foerpackningsapparatur foer i staplar frammabart styckegods
FI952490A0 (fi) Roerningsapparat foer i synnerhet kallroekning i hemhushaoll
FI952415A0 (fi) Faerrkotrollsystem foer vaetskemaengden i en behaollare
FI954315A0 (fi) Vaendanordning foer i synnerhet kylanordningar foer skivformiga stycken

Legal Events

Date Code Title Description
8364 No opposition during term of opposition